Follow us

Cornea Health and Aniridia: Gene dosage manipulation alleviates manifestations of hereditary PAX6 haploinsufficiency in mice

 
The Vision for Tomorrow Foundation continues to partner with Ali Djalilian, MD, Professor of Ophthalmology on his ongoing investigations to improve cornea health for those with aniridia and other cornea trauma. Dr. Djalilian is the Director, Stem Cell Therapy and Corneal Tissue Engineering Laboratory at the University of Illinois Eye and Ear Infirmary at the University of Illinois at Chicago. Most recently he looked at the possibility of a normal copy of a paired gene being enhanced to make up for the non-functional copy. His groundbreaking work was published in the medical journal “Science Translational Medicine”, entitled “Gene dosage manipulation alleviates manifestations of hereditary PAX6 haploinsufficiency in mice”.  VFT helped to make this work possible with a financial grant. Please consider a donation to VFT to fuel more important scientific findings that can help to better understand and more effectively treat ocular complications related to aniridia and albinism. 
 
Related Posts
Skip to content